Ads
related to: global pharma- Lab Products & Equipment
Shop our huge portfolio of labware
equipment from leading brands.
- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Solvent Center
Our Solvents include HPLC, ACS,
Anhydrous, Reagent Grade and more
- Stockroom Reagents
Solvents, Acids/Bases, Absorbents,
Filter Aids, Drying Agents and more
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Lab Products & Equipment
grandriverasepticmfg.com has been visited by 10K+ users in the past month
Search results
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid...
Digital Journal· 1 day agoVicore plans to progress buloxibutid to Phase 2b development in the first half of this year. Stockholm, May 20, 2024- Vicore Pharma Holding AB (STO: VICO), a clinical-stage ...
AstraZeneca Aims for $80 Billion in Total Revenue by 2030
US News & World Report· 8 hours agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal Soriot has turned ...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
TPT Global Tech Celebrates Successful VüMe Live PPV Events Featuring Boxing and Music Extravaganzas...
Morningstar· 5 days agoQuinton Rendell Triumphs in Comeback Fight and Sabrina Francis Rocks the Island GrenadaSAN DIEGO, CA / ACCESSWIRE / May 16, 2024 / TPT Global Tech, Inc. (OTCQB:TPTW), a trailblazer ...
FTSE 100 Live 20 May: Early blue-chip gains fade, oil rises, Ryanair hires Amber Rudd
Evening Standard via Yahoo Finance· 8 hours agoThe FTSE 100 shrugged off geopolitical concerns in early trading today, but its gains have faded in...
Taking on pharma giants, Endeavor links IPF drug to improved lung function in phase 2
FierceBiotech· 1 day agoEndeavor BioMedicines has linked its Hedgehog inhibitor to improved lung function in a phase 2a idiopathic pulmonary fibrosis (IPF) study, sending a sonic pulse through a sector currently dominated ...
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative...
Morningstar· 1 day agoSAN DIEGO, CA / ACCESSWIRE / May 20, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for ...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 5 days agoWhile AstraZeneca’s globally used COVID-19 vaccine is leaving the scene, the British Big Pharma is...
KCAS Bio expands global reach into Australia - Kansas City Business Journal
The Business Journals· 5 days agoTwo years after KCAS Bio broke into the global market, the local life sciences company is further...
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress - Innate Pharma (NASDAQ:IPHA)
Benzinga· 6 days agoTwo abstracts on SAR443579 (IPH6101), ANKET® platform lead asset, a trifunctional anti-CD123 NKp46xCD16 NK cell engager under development by partner Sanofi in blood cancer Two abstracts on IPH6501, Innate's
